Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$2.18 - $5.52 $89,896 - $227,628
41,237 Added 89.86%
87,128 $192,000
Q2 2023

Aug 14, 2023

BUY
$3.16 - $4.96 $20,255 - $31,793
6,410 Added 16.24%
45,891 $195,000
Q1 2023

May 23, 2023

BUY
$3.6 - $5.88 $41,176 - $67,255
11,438 Added 40.79%
39,481 $152,000
Q4 2022

Feb 14, 2023

BUY
$5.03 - $8.58 $17,298 - $29,506
3,439 Added 13.98%
28,043 $162,000
Q3 2022

Nov 21, 2022

BUY
$7.7 - $13.31 $9,301 - $16,078
1,208 Added 5.16%
24,604 $172,000
Q2 2022

Aug 15, 2022

BUY
$6.72 - $16.07 $157,221 - $375,973
23,396 New
23,396 $209,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $115M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.